Oligonucleotide therapy and administration: half-day pre-conference workshop

SMi Group Reports: The “Target Discovery for RNA Therapeutics” workshop will take place on Tuesday September 15, 2021 in London, UK.

LONDON, ENGLAND, UNITED KINGDOM, June 1, 2021 /EINPresswire.com/ – SMi Group is delighted to announce that the Target Discovery for RNA Therapeutics The workshop will take place on Tuesday September 15, 2021 at the Holiday Inn Forum in London, UK. The workshop will highlight Oligonucleotide therapy – the emerging class of medicine and the therapeutic benefit of target genetic material via antisense, mRNA, RNAi, saRNA and siRNA. They make it possible to assign targets considered as “non-movable”. Massive investments in the therapeutic discovery of oligonucleotides have created an emerging market need for drug delivery technologies.

For those who wish to participate in this workshop, register before June 30, 2021 to save £ 100. Subscribe to: www.oligonucleotide.co.uk / PR3 .

Martine Akerman, Chief Technology Officer, Envisagenics will lead target discovery for RNA Therapeutics. He is the inventor of SpliceCore® platform, flagship of Envisagenics AI technology for the discovery of therapeutic targets based on splicing. He obtained his doctorate in bioinformatics from Technion, Israel Institute of Technology. As a first-time entrepreneur, Martin represented Envisagenics by winning the J&J AI for Drug Discovery QuickFire Challenge in 2017 and Microsoft’s Innovate.AI Challenge in 2018. His goal is to combine cutting-edge calculations with expertise in the field of RNA to develop innovative drugs against cancer and genetic diseases.

Building on the success of our RNA Therapeutics series, we look forward to welcoming you to Oligonucleotide Therapeutics and Delivery to join the conversation about maximizing the potential of oligo-based therapies.

With this in mind, the SMi Group will bring together leading representatives from pharmaceutical, biotechnology and academic institutions to provide first-hand information on the latest clinical trial candidates and a platform for exchanging ideas to meet the most big challenge: DELIVERY.
The event brochure with agenda and list of workshops can be downloaded from the website; interested persons can register at: www.oligonucleotide.co.uk / PR3

Proudly sponsored by ChemGenes | Genscript | Tosoh Bioscience

For media inquiries, please contact Jinna Sidhu at [email protected] or call +44 (0) 20 7827 6088

About the SMi group:
Established since 1993, the SMi Group is a global event production company specializing in business-to-business conferences, workshops, masterclasses and online communities. We create and organize events in the defense, security, energy, utilities, finance and pharmacy sectors. We pride ourselves on having access to the world’s most forward-thinking thought leaders and visionaries, which allows us to bring our communities together to learn, engage, share and network. More information can be found at http://www.smi-online.co.uk

Jinna sidhu
SMi Group
+442078276088 ext.
write us here
Visit us on social networks:

Source link

About Stephen Arrington

Check Also

In workshop, landowners learn how to attract butterflies, bees and other ‘pollinators’ | Kanawha Valley

BUFFALO – The fields west of the Putnam County Toyota engine manufacturing plant will soon …

Leave a Reply

Your email address will not be published. Required fields are marked *